Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,551,382
+$82,783 QoQ
Shares Held
10,046
-0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.53%
of 13F equity value
Holder Rank
#2,139
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence Wealth Advisors, LLC holds $29,228,180 across 9 Drug Manufacturers - General names. JNJ ranks #3 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,369 | $14,835,750 | |
| 2 | ABBV |
AbbVie Inc.
|
12,831 | $3,228,792 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
10,046 | $2,551,382 | |
| 4 | AMGN |
Amgen Inc
|
6,063 | $2,195,533 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,197 | $1,919,988 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
31,560 | $1,818,487 | |
| 7 | MRK |
Merck & Co., Inc.
|
11,036 | $1,418,126 | |
| 8 | PFE |
Pfizer Inc
|
44,086 | $1,061,590 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,551,382 | 10,046 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,468,599 | 10,099 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,068,258 | 9,994 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,899,442 | 10,244 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,666,960 | 10,913 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,765,200 | 10,644 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,390,521 | 9,615 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,553,345 | 9,585 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,379,750 | 9,440 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,446,963 | 9,147 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,994,046 | 12,722 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,352,377 | 8,683 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,420,658 | 8,583 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,423,365 | 9,183 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,602,745 | 9,073 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,465,829 | 8,973 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,613,210 | 9,088 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,467,464 | 8,280 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,413,893 | 8,265 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,277,788 | 7,912 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,295,185 | 7,862 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,279,793 | 7,787 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,131,404 | 7,189 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,041,415 | 6,995 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,050,506 | 7,470 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $960,396 | 7,324 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||